Browse 700+ neutralizing antibodies with verified blocking and inhibitory activity. Designed for functional studies including cytokine neutralization, receptor-ligand blocking, viral infectivity inhibition, and pathway modulation in cell-based assays. Each antibody is validated with IC₅₀/ND₅₀ data or functional blocking assay results. All products are designated Research Use Only (RUO) — not intended for diagnostic or therapeutic procedures. RUO
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Neutralization
Human
Monoclonal
IgG1, kappa
Iv0221
Human respiratory syncytial virus A (HRSV-A), Human respiratory syncytial virus B (HRSV-B), Human metapneumovirus (HMPV)
ELISA, Neutralization
Human
Monoclonal
IgG1, kappa
M2B6
Human respiratory syncytial virus A (HRSV-A), Human respiratory syncytial virus B (HRSV-B), Human metapneumovirus (HMPV)
ELISA, Neutralization
Human
Monoclonal
IgG1, kappa
M2D2
Human respiratory syncytial virus A (HRSV-A), Human respiratory syncytial virus B (HRSV-B), Human metapneumovirus (HMPV)
ELISA, Neutralization
Human
Monoclonal
IgG1, kappa
M1C7
Influenza A virus (H3 subtype)
ELISA, Neutralization
Human
Monoclonal
IgG1
F045-092
Human adenovirus C serotype 5 (HAdV-5) (Human adenovirus 5)
ELISA, Neutralization
Human
Monoclonal
IgG1, kappa
1G2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Neutralization
Human
Monoclonal
IgG1, kappa
Iv0222
Human immunodeficiency virus type 1 (HIV-1)
Neutralization
Human
Monoclonal
IgG1
Iv0111
General
ELISA
Rabbit
Monoclonal
IgG
SAA2492
Nipah virus (NiV)
ELISA, Neutralization
Human
Monoclonal
IgG1, kappa
nAH1.3